Skip to main content
Fig. 1 | BMC Complementary Medicine and Therapies

Fig. 1

From: Jianpi Qinghua Fomula alleviates insulin resistance via restraining of MAPK pathway to suppress inflammation of the small intestine in DIO mice

Fig. 1

JPQHF ameliorated metabolic phenotype in DIO mice. A Body weight were measured weekly after JPQHF administration. B-C IPGTT and (D-E) IPPTT after 5 weeks’treatment of JPQHF. F fasting insulin (FINS), (G) cholesterol (TC), (H) triglycerides (TG), (I) low density lipoprotein cholesterol (LDL-C) and (J) high density lipoprotein cholesterol (HDL-C) concentration were detected at the 6th week. (n = 6) Values are mean ± SD. NOR: normal control; DIO: HFD induced obesity mouse; MET: metformin group(DIO mouse treated with metformin at a dose of 300 mg/kg/d; JPQH: DIO mice treated with JPQHF(20.961 g/kg/d). *P < 0.05 vs. the NOR group; **P < 0.01 vs. the NOR group; #P < 0.05 vs. the DIO group; ##P < 0.01 vs. the DIO group

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us